AngioGenex
AngioGenex is a biopharmaceutical company dedicated to the development of treatment for vascular diseases.
Business Model:
Revenue: $14.1M
Employees: 1-1
Rankings
Industries / Tags:
Detailed AngioGenex Information
Geographic Data
Address: 425 Madison Avenue
City: New York
State: NY
Zip: 10017
Country: US
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$260k
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
Contact Phone:
+13474686799
Contact Email:
AngioGenex went public on 2/9/2012 on the OTCMKTS
Listed Exchange:
OTCMKTS
IPO Date:
2/9/2012
Ticker Symbol:
AGGX
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2021 | Post-IPO Debt | $260k | 1/2005 | Venture Round | 1 | - |
Sand Hill Angels Sand Hill Angels |
4/2004 | Venture Round | 1 | $875k |
Atypical BioVentures Atypical BioVentures |
1/2005 | Venture Round | 1 | - |
Sand Hill Angels Sand Hill Angels |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
